Status:
UNKNOWN
Application of Radiomics in Precise Preoperative Diagnosis and Prognsis Evaluation of Colorectal Cancer.
Lead Sponsor:
Fudan University
Conditions:
Colorectal Cancer Stage I-IV
Eligibility:
All Genders
18-75 years
Brief Summary
This is a prospective, clinical study. This study is to collect and analyze data of radiomics of primary site or metastasis of colorectal cancer aiming to precisizing preoperative diagnosis and long-t...
Eligibility Criteria
Inclusion
- Patients with pathologically confirmed colorectal cancer
- Male or female aged 18-75 years old on the day of signing informed consent.
- Patients who received imageological examination of primary or metastasis
- Patients who received surgical resection of primary or metastasis
- Patients must have a performance status of ≤1 on the ECOG Performance Scale.
- Colorectal cancer is the only malignant tumor
- Written informed consent must be obtained from patient or patient's legal representative and ability for patient to comply with the requirements of the study
Exclusion
- Patients received adjuvant treatment prior to imageological examination
- Tis stage patients
- Paitents who diagnosed with malignant disease within 5 years.
- Patients with a history or current evidence of any condition or abnormality that might confound the results of the study, interfere with the patient's participation for the full duration of the study, or is not in the best interest of the patient to participate, in the opinion of the Investigator.
Key Trial Info
Start Date :
May 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03787667
Start Date
May 1 2018
End Date
December 31 2020
Last Update
December 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032